Russ Swan, Editor, writes:
We see from your search that you're looking for information on the term "Drug Toxicity",
and we have a large number of manufacturers' news releases and technical articles here on Laboratorytalk which will be of interest.
Let me be your guide.
Start with
the news release Apply tools and visualisations to QQQ data from
Agilent Technologies Europe, which we summarised at the time by saying "GeneSpring MS 1.1 allows import of data from 6410 triple quadrupole (QQQ) liquid chromatography/mass spectrometer (LC/MS), enabling users to analyse quantitative batch results
with statistical tools".
A few weeks before,
we featured the news release Metabolomics initiative and new website launched from
Agilent Technologies Europe: "Agilent Technologies announced at Pittcon 2007 a metabolomics initiative featuring a new website, the new Agilent Metlin personal database and a portfolio of metabolomics systems".
In December 2006, we covered the news from AnaSpec
concerning its Enzolyte alkaline phosphatase assay kits
- take a look at New line of assay kits for phosphatase detection
which says: "Protein phosphatases play key cellular regulatory roles in such processes as differentiation, proliferation and apoptosis, and have received significant attention as potential drug-screening targets".
Take a look also at the news release from Reify, Screening breakthrough for heart drug toxicity,
as well as Removing high-abundance proteins from mouse serum from Agilent Technologies Europe,
and Gene profiles from living blood from Applied Biosystems.
See also:
Column aids drug target and disease detection
(August 2003)
'Breakthrough' proteomics product simultaneously removes multiple high-abundance proteins from human blood serum
Searching for the profit in bioinformatics
(September 2002)
Bioinformatics, a combination of information technology (IT) and biological sciences, is being recognised as a potential money-spinner, by both the pharmaceuticals and pure IT companies
Hallmark indicators of drug toxicity
(January 2002)
The multiparameter Cytotoxicity 1 assay is the latest in Cellomics's series of HitKits, to quantify multiple hallmark indicators of drug toxicity in cells